Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Summit Therapeutics Inc. | 35,000 | reported | 02 Jan 2026 | tx 8+32,367,585 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Summit Therapeutics Inc. | 35,000 | — | deriv |
| 21 Oct 2025 | PURCHASE | Summit Therapeutics Inc. | 533,617 | 18.74 USD | first after silence |
| 02 Jan 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 35,000 | — | deriv |
| 02 Jan 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 5,438 | 9.18 USD | deriv |
| 07 Mar 2023 | PURCHASE | Summit Therapeutics Inc. | 21,523,530 | 1.05 USD | |
| 17 Jan 2023 | PURCHASE | Summit Therapeutics Inc. | 10,000,000 | 2.51 USD | |
| 02 Jan 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 200,000 | — | deriv |
| 02 Jan 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 35,000 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 21 Oct 2025.